{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:53:16Z","timestamp":1792806796001,"version":"4.5.0"},"reference-count":16,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health and Welfare of Taiwan","award":["MOHW113-TDU-B-212-114010"],"award-info":[{"award-number":["MOHW113-TDU-B-212-114010"]}],"id":[{"id":"https:\/\/ror.org\/024w0ge69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Cytomegalovirus (CMV) gastrointestinal (GI) diseases impact both immunocompromised and immunocompetent individuals, yet comprehensive studies highlighting the differences between these groups are lacking. Methods: In this retrospective study (January 2000 to July 2022) of 401 patients with confirmed CMV GI diseases, we categorized them based on immunological status and compared manifestations, treatments, outcomes, and prognostic factors. Results: The immunocompromised patients (n = 193) showed older age, severe illnesses, and higher comorbidity rates. GI bleeding, the predominant manifestation, occurred more in the immunocompetent group (92.6% vs. 63.6%, p = 0.009). Despite longer antiviral therapy, the immunocompromised patients had higher in-hospital (32.2% vs. 18.9%, p = 0.034) and overall mortality rates (91.1% vs. 43.4%, p &lt; 0.001). The independent factors influencing in-hospital mortality in the immunocompromised patients included GI bleeding (OR 5.782, 95% CI 1.257\u201326.599, p = 0.024) and antiviral therapy \u2265 14 days (OR 0.232, 95% CI 0.059\u20130.911, p = 0.036). In the immunocompetent patients, age (OR 1.08, 95% CI 1.006\u20131.159, p = 0.032), GI bleeding (OR 10.036, 95% CI 1.183\u201385.133, p = 0.035), and time to diagnosis (OR 1.029, 95% CI 1.004\u20131.055, p = 0.021) were significant prognostic factors, with the age and diagnosis time cut-offs for survival being 70 years and 31.5 days, respectively. Conclusions: GI bleeding is the most common manifestation and prognostic factor in both groups. Early diagnosis and effective antiviral therapy can significantly reduce in-hospital mortality.<\/jats:p>","DOI":"10.3390\/v16030452","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:02:39Z","timestamp":1710504159000},"page":"452","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Analysis of Cytomegalovirus Gastrointestinal Disease in Immunocompetent and Immunocompromised Patients"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-5677","authenticated-orcid":false,"given":"Pai-Jui","family":"Yeh","sequence":"first","affiliation":[{"name":"Department of Pediatric Gastroenterology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-0874","authenticated-orcid":false,"given":"Ren-Chin","family":"Wu","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Department of Anatomic Pathology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kuan","family":"Tsou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1504","authenticated-orcid":false,"given":"Chien-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Department of Medical Imaging and Interventions, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Tang","family":"Chiu","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Taiwan Association of the Study of Small Intestinal Disease, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2881-3973","authenticated-orcid":false,"given":"Chien-Chang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-1526","authenticated-orcid":false,"given":"Yu-Bin","family":"Pan","sequence":"additional","affiliation":[{"name":"Biostatistical Section, Clinical Trial Center, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-5371","authenticated-orcid":false,"given":"Puo-Hsien","family":"Le","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan"},{"name":"Taiwan Association of the Study of Small Intestinal Disease, Taoyuan 333, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Fowler, K., Mucha, J., Neumann, M., Lewandowski, W., Kaczanowska, M., Grys, M., Schmidt, E., Natenshon, A., Talarico, C., and Buck, P.O. (2022). A systematic literature review of the global seroprevalence of cytomegalovirus: Possible implications for treatment, screening, and vaccine development. BMC Public. Health, 22.","DOI":"10.1186\/s12889-022-13971-7"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","article-title":"Ulcerative Colitis and Cytomegalovirus Infection: From A to Z","volume":"14","author":"Mourad","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","article-title":"New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant\/Refractory Disease","volume":"12","author":"Kotton","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106860","DOI":"10.1016\/j.ijantimicag.2023.106860","article-title":"Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants","volume":"62","author":"Allaw","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11894-012-0266-4","article-title":"Cytomegalovirus infection and the gastrointestinal tract","volume":"14","author":"You","year":"2012","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yeh, P.J., Wu, R.C., Chiu, C.T., Lai, M.W., Chen, C.M., Pan, Y.B., Su, M.Y., Kuo, C.J., Lin, W.R., and Le, P.H. (2022). Cytomegalovirus Diseases of the Gastrointestinal Tract. Viruses, 14.","DOI":"10.3390\/v14020352"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8886525","DOI":"10.1155\/2021\/8886525","article-title":"Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients","volume":"2021","author":"Wetwittayakhlang","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chaemsupaphan, T., Limsrivilai, J., Thongdee, C., Sudcharoen, A., Pongpaibul, A., Pausawasdi, N., and Charatcharoenwitthaya, P. (2020). Patient characteristics, clinical manifestations, prognosis, and factors associated with gastrointestinal cytomegalovirus infection in immunocompetent patients. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-1174-y"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1038\/s41598-021-85845-8","article-title":"Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients","volume":"11","author":"Yoon","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_11","unstructured":"Rich, R.R., Fleisher, T.A., Shearer, W.T., Schroeder, H.W., Frew, A.J., and Weyand, C.M. (2008). Clinical Immunology, Mosby. [3rd ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e14083","DOI":"10.1111\/tid.14083","article-title":"Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review","volume":"25","author":"Cho","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmi.2022.07.001","article-title":"Cytomegalovirus infection in transplant recipients: Newly approved additions to our armamentarium","volume":"29","author":"Khawaja","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hiv.13004","article-title":"British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of gastrointestinal opportunistic infections 2020","volume":"21","author":"Chadwick","year":"2020","journal-title":"HIV Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/3\/452\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:13:41Z","timestamp":1760105621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/3\/452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["v16030452"],"URL":"https:\/\/doi.org\/10.3390\/v16030452","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}